nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—ABCB1—Desloratadine—allergic rhinitis	0.0677	0.0969	CbGbCtD
Dabrafenib—ABCG2—Hydrocortisone—allergic rhinitis	0.06	0.0859	CbGbCtD
Dabrafenib—CYP2C8—Montelukast—allergic rhinitis	0.0574	0.0822	CbGbCtD
Dabrafenib—CYP2C8—Loratadine—allergic rhinitis	0.0574	0.0822	CbGbCtD
Dabrafenib—CYP3A4—Flunisolide—allergic rhinitis	0.0406	0.0581	CbGbCtD
Dabrafenib—ABCB1—Loratadine—allergic rhinitis	0.0389	0.0557	CbGbCtD
Dabrafenib—CYP3A4—Olopatadine—allergic rhinitis	0.0381	0.0546	CbGbCtD
Dabrafenib—ABCG2—Dexamethasone—allergic rhinitis	0.0373	0.0534	CbGbCtD
Dabrafenib—ABCB1—Methylprednisolone—allergic rhinitis	0.0356	0.0509	CbGbCtD
Dabrafenib—CYP2C8—Hydrocortisone—allergic rhinitis	0.0319	0.0457	CbGbCtD
Dabrafenib—CYP3A4—Loratadine—allergic rhinitis	0.0233	0.0334	CbGbCtD
Dabrafenib—CYP3A4—Montelukast—allergic rhinitis	0.0233	0.0334	CbGbCtD
Dabrafenib—ABCB1—Betamethasone—allergic rhinitis	0.0231	0.0331	CbGbCtD
Dabrafenib—ABCB1—Prednisolone—allergic rhinitis	0.0228	0.0327	CbGbCtD
Dabrafenib—ABCB1—Hydrocortisone—allergic rhinitis	0.0216	0.031	CbGbCtD
Dabrafenib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0213	0.0305	CbGbCtD
Dabrafenib—CYP2C8—Dexamethasone—allergic rhinitis	0.0199	0.0285	CbGbCtD
Dabrafenib—CYP3A4—Triamcinolone—allergic rhinitis	0.0161	0.0231	CbGbCtD
Dabrafenib—CYP3A4—Betamethasone—allergic rhinitis	0.0139	0.0198	CbGbCtD
Dabrafenib—CYP3A4—Prednisolone—allergic rhinitis	0.0137	0.0196	CbGbCtD
Dabrafenib—ABCB1—Dexamethasone—allergic rhinitis	0.0134	0.0193	CbGbCtD
Dabrafenib—CYP3A4—Hydrocortisone—allergic rhinitis	0.013	0.0186	CbGbCtD
Dabrafenib—CYP3A4—Dexamethasone—allergic rhinitis	0.00806	0.0115	CbGbCtD
Dabrafenib—NEK11—lung—allergic rhinitis	0.00325	0.126	CbGeAlD
Dabrafenib—SIK1—respiratory system—allergic rhinitis	0.00226	0.0881	CbGeAlD
Dabrafenib—SIK1—bronchus—allergic rhinitis	0.00186	0.0725	CbGeAlD
Dabrafenib—RAF1—respiratory system—allergic rhinitis	0.0018	0.0701	CbGeAlD
Dabrafenib—SIK1—skin of body—allergic rhinitis	0.0018	0.07	CbGeAlD
Dabrafenib—RAF1—eye—allergic rhinitis	0.00165	0.0641	CbGeAlD
Dabrafenib—RAF1—epithelium—allergic rhinitis	0.00151	0.0586	CbGeAlD
Dabrafenib—RAF1—bronchus—allergic rhinitis	0.00148	0.0577	CbGeAlD
Dabrafenib—BRAF—lung—allergic rhinitis	0.00144	0.0559	CbGeAlD
Dabrafenib—RAF1—skin of body—allergic rhinitis	0.00143	0.0557	CbGeAlD
Dabrafenib—RAF1—trachea—allergic rhinitis	0.00133	0.0518	CbGeAlD
Dabrafenib—SLCO1B3—lung—allergic rhinitis	0.00124	0.0482	CbGeAlD
Dabrafenib—SIK1—lung—allergic rhinitis	0.0012	0.0468	CbGeAlD
Dabrafenib—SLC22A8—eye—allergic rhinitis	0.000957	0.0372	CbGeAlD
Dabrafenib—RAF1—lung—allergic rhinitis	0.000956	0.0372	CbGeAlD
Dabrafenib—Dermatitis bullous—Dexamethasone—allergic rhinitis	0.000404	0.00149	CcSEcCtD
Dabrafenib—Dermatitis bullous—Betamethasone—allergic rhinitis	0.000404	0.00149	CcSEcCtD
Dabrafenib—Nervous system disorder—Montelukast—allergic rhinitis	0.000403	0.00149	CcSEcCtD
Dabrafenib—Thrombocytopenia—Montelukast—allergic rhinitis	0.000403	0.00149	CcSEcCtD
Dabrafenib—Nausea—Diphenhydramine—allergic rhinitis	0.000402	0.00148	CcSEcCtD
Dabrafenib—Nausea—Dimenhydrinate—allergic rhinitis	0.000402	0.00148	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Cetirizine—allergic rhinitis	0.000401	0.00148	CcSEcCtD
Dabrafenib—Skin disorder—Montelukast—allergic rhinitis	0.000399	0.00148	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000399	0.00147	CcSEcCtD
Dabrafenib—ABCG2—lung—allergic rhinitis	0.000396	0.0154	CbGeAlD
Dabrafenib—Gastrointestinal pain—Flunisolide—allergic rhinitis	0.000394	0.00146	CcSEcCtD
Dabrafenib—Pancreatitis—Prednisolone—allergic rhinitis	0.000392	0.00145	CcSEcCtD
Dabrafenib—Abdominal pain—Cetirizine—allergic rhinitis	0.000388	0.00143	CcSEcCtD
Dabrafenib—Body temperature increased—Cetirizine—allergic rhinitis	0.000388	0.00143	CcSEcCtD
Dabrafenib—Pancreatitis—Hydrocortisone—allergic rhinitis	0.000383	0.00141	CcSEcCtD
Dabrafenib—Body temperature increased—Flunisolide—allergic rhinitis	0.000381	0.00141	CcSEcCtD
Dabrafenib—Abdominal pain—Flunisolide—allergic rhinitis	0.000381	0.00141	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000375	0.00138	CcSEcCtD
Dabrafenib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000374	0.00138	CcSEcCtD
Dabrafenib—Asthenia—Loratadine—allergic rhinitis	0.000374	0.00138	CcSEcCtD
Dabrafenib—Insomnia—Montelukast—allergic rhinitis	0.000372	0.00137	CcSEcCtD
Dabrafenib—ABCB1—respiratory system—allergic rhinitis	0.000367	0.0143	CbGeAlD
Dabrafenib—Hypersensitivity—Cetirizine—allergic rhinitis	0.000361	0.00133	CcSEcCtD
Dabrafenib—Pancreatitis—Triamcinolone—allergic rhinitis	0.000361	0.00133	CcSEcCtD
Dabrafenib—Pancreatitis—Methylprednisolone—allergic rhinitis	0.00036	0.00133	CcSEcCtD
Dabrafenib—Diarrhoea—Loratadine—allergic rhinitis	0.000357	0.00132	CcSEcCtD
Dabrafenib—Hypersensitivity—Flunisolide—allergic rhinitis	0.000355	0.00131	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000355	0.00131	CcSEcCtD
Dabrafenib—Fatigue—Montelukast—allergic rhinitis	0.000355	0.00131	CcSEcCtD
Dabrafenib—Dry skin—Dexamethasone—allergic rhinitis	0.000354	0.00131	CcSEcCtD
Dabrafenib—Dry skin—Betamethasone—allergic rhinitis	0.000354	0.00131	CcSEcCtD
Dabrafenib—Asthenia—Cetirizine—allergic rhinitis	0.000352	0.0013	CcSEcCtD
Dabrafenib—Hypokalaemia—Betamethasone—allergic rhinitis	0.000351	0.0013	CcSEcCtD
Dabrafenib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000351	0.0013	CcSEcCtD
Dabrafenib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000348	0.00129	CcSEcCtD
Dabrafenib—Infestation—Hydrocortisone—allergic rhinitis	0.000348	0.00129	CcSEcCtD
Dabrafenib—Pruritus—Cetirizine—allergic rhinitis	0.000347	0.00128	CcSEcCtD
Dabrafenib—Asthenia—Flunisolide—allergic rhinitis	0.000346	0.00128	CcSEcCtD
Dabrafenib—Dizziness—Loratadine—allergic rhinitis	0.000345	0.00127	CcSEcCtD
Dabrafenib—Pruritus—Flunisolide—allergic rhinitis	0.000341	0.00126	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000336	0.00124	CcSEcCtD
Dabrafenib—Diarrhoea—Cetirizine—allergic rhinitis	0.000336	0.00124	CcSEcCtD
Dabrafenib—SIK1—TGF-beta Signaling Pathway—FOXP3—allergic rhinitis	0.000331	0.0641	CbGpPWpGaD
Dabrafenib—Vomiting—Loratadine—allergic rhinitis	0.000331	0.00122	CcSEcCtD
Dabrafenib—Diarrhoea—Flunisolide—allergic rhinitis	0.00033	0.00122	CcSEcCtD
Dabrafenib—Rash—Loratadine—allergic rhinitis	0.000329	0.00121	CcSEcCtD
Dabrafenib—Dermatitis—Loratadine—allergic rhinitis	0.000328	0.00121	CcSEcCtD
Dabrafenib—Infestation—Methylprednisolone—allergic rhinitis	0.000327	0.00121	CcSEcCtD
Dabrafenib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000327	0.00121	CcSEcCtD
Dabrafenib—Headache—Loratadine—allergic rhinitis	0.000327	0.00121	CcSEcCtD
Dabrafenib—Body temperature increased—Montelukast—allergic rhinitis	0.000325	0.0012	CcSEcCtD
Dabrafenib—Abdominal pain—Montelukast—allergic rhinitis	0.000325	0.0012	CcSEcCtD
Dabrafenib—Dizziness—Cetirizine—allergic rhinitis	0.000324	0.0012	CcSEcCtD
Dabrafenib—Haemoglobin—Prednisolone—allergic rhinitis	0.000322	0.00119	CcSEcCtD
Dabrafenib—Haemorrhage—Prednisolone—allergic rhinitis	0.00032	0.00118	CcSEcCtD
Dabrafenib—Dizziness—Flunisolide—allergic rhinitis	0.000319	0.00118	CcSEcCtD
Dabrafenib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000314	0.00116	CcSEcCtD
Dabrafenib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000313	0.00115	CcSEcCtD
Dabrafenib—Vomiting—Cetirizine—allergic rhinitis	0.000312	0.00115	CcSEcCtD
Dabrafenib—Nausea—Loratadine—allergic rhinitis	0.00031	0.00114	CcSEcCtD
Dabrafenib—Epistaxis—Triamcinolone—allergic rhinitis	0.000309	0.00114	CcSEcCtD
Dabrafenib—Rash—Cetirizine—allergic rhinitis	0.000309	0.00114	CcSEcCtD
Dabrafenib—Dermatitis—Cetirizine—allergic rhinitis	0.000309	0.00114	CcSEcCtD
Dabrafenib—Headache—Cetirizine—allergic rhinitis	0.000307	0.00113	CcSEcCtD
Dabrafenib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000307	0.00113	CcSEcCtD
Dabrafenib—ABCB1—epithelium—allergic rhinitis	0.000307	0.012	CbGeAlD
Dabrafenib—Vomiting—Flunisolide—allergic rhinitis	0.000307	0.00113	CcSEcCtD
Dabrafenib—Rash—Flunisolide—allergic rhinitis	0.000304	0.00112	CcSEcCtD
Dabrafenib—Dermatitis—Flunisolide—allergic rhinitis	0.000304	0.00112	CcSEcCtD
Dabrafenib—Hypersensitivity—Montelukast—allergic rhinitis	0.000303	0.00112	CcSEcCtD
Dabrafenib—Headache—Flunisolide—allergic rhinitis	0.000302	0.00112	CcSEcCtD
Dabrafenib—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000301	0.00111	CcSEcCtD
Dabrafenib—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000301	0.00111	CcSEcCtD
Dabrafenib—Haemoglobin—Triamcinolone—allergic rhinitis	0.000296	0.00109	CcSEcCtD
Dabrafenib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000295	0.00109	CcSEcCtD
Dabrafenib—Asthenia—Montelukast—allergic rhinitis	0.000295	0.00109	CcSEcCtD
Dabrafenib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000294	0.00109	CcSEcCtD
Dabrafenib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000294	0.00108	CcSEcCtD
Dabrafenib—Eye disorder—Hydrocortisone—allergic rhinitis	0.000292	0.00108	CcSEcCtD
Dabrafenib—Nausea—Cetirizine—allergic rhinitis	0.000291	0.00108	CcSEcCtD
Dabrafenib—Pruritus—Montelukast—allergic rhinitis	0.000291	0.00107	CcSEcCtD
Dabrafenib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000289	0.00107	CcSEcCtD
Dabrafenib—Nausea—Flunisolide—allergic rhinitis	0.000286	0.00106	CcSEcCtD
Dabrafenib—Arrhythmia—Prednisolone—allergic rhinitis	0.000286	0.00106	CcSEcCtD
Dabrafenib—Immune system disorder—Hydrocortisone—allergic rhinitis	0.000282	0.00104	CcSEcCtD
Dabrafenib—Diarrhoea—Montelukast—allergic rhinitis	0.000281	0.00104	CcSEcCtD
Dabrafenib—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000279	0.00103	CcSEcCtD
Dabrafenib—Erythema—Prednisolone—allergic rhinitis	0.000279	0.00103	CcSEcCtD
Dabrafenib—Eye disorder—Methylprednisolone—allergic rhinitis	0.000274	0.00101	CcSEcCtD
Dabrafenib—Mental disorder—Hydrocortisone—allergic rhinitis	0.000274	0.00101	CcSEcCtD
Dabrafenib—Erythema—Hydrocortisone—allergic rhinitis	0.000272	0.001	CcSEcCtD
Dabrafenib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000272	0.001	CcSEcCtD
Dabrafenib—Dizziness—Montelukast—allergic rhinitis	0.000272	0.001	CcSEcCtD
Dabrafenib—ABCB1—trachea—allergic rhinitis	0.000271	0.0106	CbGeAlD
Dabrafenib—Haemoglobin—Betamethasone—allergic rhinitis	0.000268	0.000991	CcSEcCtD
Dabrafenib—Haemoglobin—Dexamethasone—allergic rhinitis	0.000268	0.000991	CcSEcCtD
Dabrafenib—Haemorrhage—Dexamethasone—allergic rhinitis	0.000267	0.000986	CcSEcCtD
Dabrafenib—Haemorrhage—Betamethasone—allergic rhinitis	0.000267	0.000986	CcSEcCtD
Dabrafenib—Angiopathy—Methylprednisolone—allergic rhinitis	0.000266	0.000984	CcSEcCtD
Dabrafenib—LIMK1—Axon guidance—PFN2—allergic rhinitis	0.000266	0.0515	CbGpPWpGaD
Dabrafenib—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000265	0.00098	CcSEcCtD
Dabrafenib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000265	0.000977	CcSEcCtD
Dabrafenib—Arrhythmia—Triamcinolone—allergic rhinitis	0.000263	0.000971	CcSEcCtD
Dabrafenib—Vision blurred—Prednisolone—allergic rhinitis	0.000263	0.00097	CcSEcCtD
Dabrafenib—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000262	0.000969	CcSEcCtD
Dabrafenib—Vomiting—Montelukast—allergic rhinitis	0.000261	0.000966	CcSEcCtD
Dabrafenib—Rash—Montelukast—allergic rhinitis	0.000259	0.000958	CcSEcCtD
Dabrafenib—Dermatitis—Montelukast—allergic rhinitis	0.000259	0.000957	CcSEcCtD
Dabrafenib—Headache—Montelukast—allergic rhinitis	0.000258	0.000951	CcSEcCtD
Dabrafenib—Mental disorder—Methylprednisolone—allergic rhinitis	0.000257	0.00095	CcSEcCtD
Dabrafenib—Erythema—Triamcinolone—allergic rhinitis	0.000256	0.000946	CcSEcCtD
Dabrafenib—Erythema—Methylprednisolone—allergic rhinitis	0.000256	0.000944	CcSEcCtD
Dabrafenib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000256	0.000944	CcSEcCtD
Dabrafenib—Eye disorder—Dexamethasone—allergic rhinitis	0.00025	0.000922	CcSEcCtD
Dabrafenib—Eye disorder—Betamethasone—allergic rhinitis	0.00025	0.000922	CcSEcCtD
Dabrafenib—Back pain—Triamcinolone—allergic rhinitis	0.000248	0.000915	CcSEcCtD
Dabrafenib—Nausea—Montelukast—allergic rhinitis	0.000244	0.000902	CcSEcCtD
Dabrafenib—Angiopathy—Betamethasone—allergic rhinitis	0.000242	0.000895	CcSEcCtD
Dabrafenib—Angiopathy—Dexamethasone—allergic rhinitis	0.000242	0.000895	CcSEcCtD
Dabrafenib—Hypertension—Prednisolone—allergic rhinitis	0.000241	0.000888	CcSEcCtD
Dabrafenib—Arrhythmia—Betamethasone—allergic rhinitis	0.000239	0.000881	CcSEcCtD
Dabrafenib—Arrhythmia—Dexamethasone—allergic rhinitis	0.000239	0.000881	CcSEcCtD
Dabrafenib—Alopecia—Dexamethasone—allergic rhinitis	0.000236	0.000872	CcSEcCtD
Dabrafenib—Alopecia—Betamethasone—allergic rhinitis	0.000236	0.000872	CcSEcCtD
Dabrafenib—Hypertension—Hydrocortisone—allergic rhinitis	0.000235	0.000868	CcSEcCtD
Dabrafenib—Erythema—Dexamethasone—allergic rhinitis	0.000232	0.000859	CcSEcCtD
Dabrafenib—Erythema—Betamethasone—allergic rhinitis	0.000232	0.000859	CcSEcCtD
Dabrafenib—Myalgia—Hydrocortisone—allergic rhinitis	0.000232	0.000856	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.00023	0.00085	CcSEcCtD
Dabrafenib—Oedema—Prednisolone—allergic rhinitis	0.000227	0.00084	CcSEcCtD
Dabrafenib—Cough—Triamcinolone—allergic rhinitis	0.000224	0.000826	CcSEcCtD
Dabrafenib—Oedema—Hydrocortisone—allergic rhinitis	0.000222	0.00082	CcSEcCtD
Dabrafenib—Hypertension—Triamcinolone—allergic rhinitis	0.000221	0.000817	CcSEcCtD
Dabrafenib—Hypertension—Methylprednisolone—allergic rhinitis	0.000221	0.000815	CcSEcCtD
Dabrafenib—Infection—Hydrocortisone—allergic rhinitis	0.000221	0.000815	CcSEcCtD
Dabrafenib—Hyperhidrosis—Prednisolone—allergic rhinitis	0.00022	0.000812	CcSEcCtD
Dabrafenib—Myalgia—Triamcinolone—allergic rhinitis	0.000218	0.000806	CcSEcCtD
Dabrafenib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000218	0.000804	CcSEcCtD
Dabrafenib—Arthralgia—Methylprednisolone—allergic rhinitis	0.000218	0.000804	CcSEcCtD
Dabrafenib—Myalgia—Methylprednisolone—allergic rhinitis	0.000218	0.000804	CcSEcCtD
Dabrafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000216	0.000798	CcSEcCtD
Dabrafenib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000216	0.000797	CcSEcCtD
Dabrafenib—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.000215	0.000793	CcSEcCtD
Dabrafenib—Dry mouth—Triamcinolone—allergic rhinitis	0.000213	0.000788	CcSEcCtD
Dabrafenib—Oedema—Triamcinolone—allergic rhinitis	0.000209	0.000772	CcSEcCtD
Dabrafenib—Infection—Triamcinolone—allergic rhinitis	0.000208	0.000767	CcSEcCtD
Dabrafenib—Hypotension—Hydrocortisone—allergic rhinitis	0.000208	0.000766	CcSEcCtD
Dabrafenib—Infection—Methylprednisolone—allergic rhinitis	0.000207	0.000766	CcSEcCtD
Dabrafenib—Insomnia—Prednisolone—allergic rhinitis	0.000206	0.00076	CcSEcCtD
Dabrafenib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000205	0.000756	CcSEcCtD
Dabrafenib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000203	0.000748	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000202	0.000747	CcSEcCtD
Dabrafenib—Hyperhidrosis—Triamcinolone—allergic rhinitis	0.000202	0.000747	CcSEcCtD
Dabrafenib—Hyperhidrosis—Methylprednisolone—allergic rhinitis	0.000202	0.000745	CcSEcCtD
Dabrafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.000201	0.0389	CbGpPWpGaD
Dabrafenib—Insomnia—Hydrocortisone—allergic rhinitis	0.000201	0.000742	CcSEcCtD
Dabrafenib—Hypertension—Betamethasone—allergic rhinitis	0.000201	0.000741	CcSEcCtD
Dabrafenib—Hypertension—Dexamethasone—allergic rhinitis	0.000201	0.000741	CcSEcCtD
Dabrafenib—Myalgia—Dexamethasone—allergic rhinitis	0.000198	0.000731	CcSEcCtD
Dabrafenib—Myalgia—Betamethasone—allergic rhinitis	0.000198	0.000731	CcSEcCtD
Dabrafenib—ABCB1—lung—allergic rhinitis	0.000195	0.00759	CbGeAlD
Dabrafenib—Hypotension—Methylprednisolone—allergic rhinitis	0.000195	0.00072	CcSEcCtD
Dabrafenib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000193	0.000713	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000192	0.000708	CcSEcCtD
Dabrafenib—Fatigue—Hydrocortisone—allergic rhinitis	0.000191	0.000707	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000191	0.000704	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.00019	0.000702	CcSEcCtD
Dabrafenib—LIMK1—Developmental Biology—PFN2—allergic rhinitis	0.00019	0.0367	CbGpPWpGaD
Dabrafenib—Oedema—Betamethasone—allergic rhinitis	0.00019	0.000701	CcSEcCtD
Dabrafenib—Oedema—Dexamethasone—allergic rhinitis	0.00019	0.000701	CcSEcCtD
Dabrafenib—Insomnia—Triamcinolone—allergic rhinitis	0.000189	0.000698	CcSEcCtD
Dabrafenib—RAF1—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.000189	0.0366	CbGpPWpGaD
Dabrafenib—Insomnia—Methylprednisolone—allergic rhinitis	0.000189	0.000697	CcSEcCtD
Dabrafenib—Infection—Dexamethasone—allergic rhinitis	0.000189	0.000696	CcSEcCtD
Dabrafenib—Infection—Betamethasone—allergic rhinitis	0.000189	0.000696	CcSEcCtD
Dabrafenib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000186	0.000687	CcSEcCtD
Dabrafenib—Nervous system disorder—Betamethasone—allergic rhinitis	0.000186	0.000687	CcSEcCtD
Dabrafenib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000186	0.000686	CcSEcCtD
Dabrafenib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000186	0.000686	CcSEcCtD
Dabrafenib—Hyperhidrosis—Betamethasone—allergic rhinitis	0.000183	0.000677	CcSEcCtD
Dabrafenib—Hyperhidrosis—Dexamethasone—allergic rhinitis	0.000183	0.000677	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000182	0.000671	CcSEcCtD
Dabrafenib—Fatigue—Triamcinolone—allergic rhinitis	0.00018	0.000666	CcSEcCtD
Dabrafenib—Fatigue—Methylprednisolone—allergic rhinitis	0.00018	0.000664	CcSEcCtD
Dabrafenib—Hypotension—Dexamethasone—allergic rhinitis	0.000177	0.000655	CcSEcCtD
Dabrafenib—Hypotension—Betamethasone—allergic rhinitis	0.000177	0.000655	CcSEcCtD
Dabrafenib—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000176	0.000648	CcSEcCtD
Dabrafenib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000176	0.000648	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000173	0.000638	CcSEcCtD
Dabrafenib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000173	0.000638	CcSEcCtD
Dabrafenib—Insomnia—Betamethasone—allergic rhinitis	0.000172	0.000634	CcSEcCtD
Dabrafenib—Insomnia—Dexamethasone—allergic rhinitis	0.000172	0.000634	CcSEcCtD
Dabrafenib—SIK1—TGF-beta Signaling Pathway—SMAD3—allergic rhinitis	0.000171	0.033	CbGpPWpGaD
Dabrafenib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000171	0.00063	CcSEcCtD
Dabrafenib—SIK1—Circadian rythm related genes—ADIPOQ—allergic rhinitis	0.000168	0.0325	CbGpPWpGaD
Dabrafenib—Hypersensitivity—Prednisolone—allergic rhinitis	0.000168	0.000619	CcSEcCtD
Dabrafenib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000165	0.000611	CcSEcCtD
Dabrafenib—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000165	0.000609	CcSEcCtD
Dabrafenib—Decreased appetite—Betamethasone—allergic rhinitis	0.000165	0.000609	CcSEcCtD
Dabrafenib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000165	0.000609	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000164	0.000605	CcSEcCtD
Dabrafenib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000164	0.000605	CcSEcCtD
Dabrafenib—Hypersensitivity—Hydrocortisone—allergic rhinitis	0.000164	0.000604	CcSEcCtD
Dabrafenib—Fatigue—Betamethasone—allergic rhinitis	0.000164	0.000604	CcSEcCtD
Dabrafenib—Fatigue—Dexamethasone—allergic rhinitis	0.000164	0.000604	CcSEcCtD
Dabrafenib—Asthenia—Hydrocortisone—allergic rhinitis	0.000159	0.000588	CcSEcCtD
Dabrafenib—Pruritus—Hydrocortisone—allergic rhinitis	0.000157	0.00058	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000155	0.000573	CcSEcCtD
Dabrafenib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000155	0.000573	CcSEcCtD
Dabrafenib—Hypersensitivity—Triamcinolone—allergic rhinitis	0.000154	0.000569	CcSEcCtD
Dabrafenib—Hypersensitivity—Methylprednisolone—allergic rhinitis	0.000154	0.000568	CcSEcCtD
Dabrafenib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000152	0.000561	CcSEcCtD
Dabrafenib—Dizziness—Prednisolone—allergic rhinitis	0.00015	0.000555	CcSEcCtD
Dabrafenib—Asthenia—Triamcinolone—allergic rhinitis	0.00015	0.000554	CcSEcCtD
Dabrafenib—Abdominal pain—Betamethasone—allergic rhinitis	0.00015	0.000554	CcSEcCtD
Dabrafenib—Abdominal pain—Dexamethasone—allergic rhinitis	0.00015	0.000554	CcSEcCtD
Dabrafenib—Body temperature increased—Dexamethasone—allergic rhinitis	0.00015	0.000554	CcSEcCtD
Dabrafenib—Body temperature increased—Betamethasone—allergic rhinitis	0.00015	0.000554	CcSEcCtD
Dabrafenib—Asthenia—Methylprednisolone—allergic rhinitis	0.00015	0.000553	CcSEcCtD
Dabrafenib—Pruritus—Triamcinolone—allergic rhinitis	0.000148	0.000546	CcSEcCtD
Dabrafenib—Pruritus—Methylprednisolone—allergic rhinitis	0.000148	0.000545	CcSEcCtD
Dabrafenib—Dizziness—Hydrocortisone—allergic rhinitis	0.000147	0.000542	CcSEcCtD
Dabrafenib—Rash—Prednisolone—allergic rhinitis	0.000143	0.00053	CcSEcCtD
Dabrafenib—Dermatitis—Prednisolone—allergic rhinitis	0.000143	0.000529	CcSEcCtD
Dabrafenib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000143	0.000527	CcSEcCtD
Dabrafenib—Headache—Prednisolone—allergic rhinitis	0.000142	0.000526	CcSEcCtD
Dabrafenib—Vomiting—Hydrocortisone—allergic rhinitis	0.000141	0.000521	CcSEcCtD
Dabrafenib—Rash—Hydrocortisone—allergic rhinitis	0.00014	0.000517	CcSEcCtD
Dabrafenib—Dermatitis—Hydrocortisone—allergic rhinitis	0.00014	0.000517	CcSEcCtD
Dabrafenib—Headache—Hydrocortisone—allergic rhinitis	0.000139	0.000514	CcSEcCtD
Dabrafenib—Dizziness—Triamcinolone—allergic rhinitis	0.000138	0.000511	CcSEcCtD
Dabrafenib—Dizziness—Methylprednisolone—allergic rhinitis	0.000138	0.00051	CcSEcCtD
Dabrafenib—Asthenia—Dexamethasone—allergic rhinitis	0.000136	0.000503	CcSEcCtD
Dabrafenib—Asthenia—Betamethasone—allergic rhinitis	0.000136	0.000503	CcSEcCtD
Dabrafenib—Nausea—Prednisolone—allergic rhinitis	0.000135	0.000499	CcSEcCtD
Dabrafenib—Pruritus—Betamethasone—allergic rhinitis	0.000134	0.000496	CcSEcCtD
Dabrafenib—Pruritus—Dexamethasone—allergic rhinitis	0.000134	0.000496	CcSEcCtD
Dabrafenib—Vomiting—Triamcinolone—allergic rhinitis	0.000133	0.000491	CcSEcCtD
Dabrafenib—Vomiting—Methylprednisolone—allergic rhinitis	0.000133	0.00049	CcSEcCtD
Dabrafenib—Nausea—Hydrocortisone—allergic rhinitis	0.000132	0.000487	CcSEcCtD
Dabrafenib—Rash—Triamcinolone—allergic rhinitis	0.000132	0.000487	CcSEcCtD
Dabrafenib—Dermatitis—Triamcinolone—allergic rhinitis	0.000132	0.000486	CcSEcCtD
Dabrafenib—Rash—Methylprednisolone—allergic rhinitis	0.000132	0.000486	CcSEcCtD
Dabrafenib—Dermatitis—Methylprednisolone—allergic rhinitis	0.000131	0.000485	CcSEcCtD
Dabrafenib—Headache—Triamcinolone—allergic rhinitis	0.000131	0.000484	CcSEcCtD
Dabrafenib—Headache—Methylprednisolone—allergic rhinitis	0.000131	0.000483	CcSEcCtD
Dabrafenib—RAF1—Endothelins—CYSLTR1—allergic rhinitis	0.000131	0.0253	CbGpPWpGaD
Dabrafenib—Diarrhoea—Betamethasone—allergic rhinitis	0.00013	0.000479	CcSEcCtD
Dabrafenib—Diarrhoea—Dexamethasone—allergic rhinitis	0.00013	0.000479	CcSEcCtD
Dabrafenib—Dizziness—Betamethasone—allergic rhinitis	0.000125	0.000463	CcSEcCtD
Dabrafenib—Dizziness—Dexamethasone—allergic rhinitis	0.000125	0.000463	CcSEcCtD
Dabrafenib—Nausea—Triamcinolone—allergic rhinitis	0.000124	0.000459	CcSEcCtD
Dabrafenib—Nausea—Methylprednisolone—allergic rhinitis	0.000124	0.000458	CcSEcCtD
Dabrafenib—Vomiting—Betamethasone—allergic rhinitis	0.000121	0.000446	CcSEcCtD
Dabrafenib—Vomiting—Dexamethasone—allergic rhinitis	0.000121	0.000446	CcSEcCtD
Dabrafenib—Rash—Betamethasone—allergic rhinitis	0.00012	0.000442	CcSEcCtD
Dabrafenib—Rash—Dexamethasone—allergic rhinitis	0.00012	0.000442	CcSEcCtD
Dabrafenib—Dermatitis—Dexamethasone—allergic rhinitis	0.00012	0.000441	CcSEcCtD
Dabrafenib—Dermatitis—Betamethasone—allergic rhinitis	0.00012	0.000441	CcSEcCtD
Dabrafenib—Headache—Dexamethasone—allergic rhinitis	0.000119	0.000439	CcSEcCtD
Dabrafenib—Headache—Betamethasone—allergic rhinitis	0.000119	0.000439	CcSEcCtD
Dabrafenib—Nausea—Betamethasone—allergic rhinitis	0.000113	0.000416	CcSEcCtD
Dabrafenib—Nausea—Dexamethasone—allergic rhinitis	0.000113	0.000416	CcSEcCtD
Dabrafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—allergic rhinitis	0.000109	0.021	CbGpPWpGaD
Dabrafenib—RAF1—Interleukin-2 signaling—IL5—allergic rhinitis	0.000108	0.0208	CbGpPWpGaD
Dabrafenib—BRAF—Estrogen signaling pathway—NFKB1—allergic rhinitis	9.87e-05	0.0191	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—MS4A2—allergic rhinitis	9.62e-05	0.0186	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—PFN2—allergic rhinitis	9.2e-05	0.0178	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	8.57e-05	0.0166	CbGpPWpGaD
Dabrafenib—LIMK1—CXCR4-mediated signaling events—CD4—allergic rhinitis	8.13e-05	0.0157	CbGpPWpGaD
Dabrafenib—SIK1—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	7.23e-05	0.014	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—IL17A—allergic rhinitis	6.89e-05	0.0133	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—PFN2—allergic rhinitis	6.56e-05	0.0127	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—FOXP3—allergic rhinitis	6.44e-05	0.0125	CbGpPWpGaD
Dabrafenib—RAF1—Interleukin-11 Signaling Pathway—ICAM1—allergic rhinitis	6.42e-05	0.0124	CbGpPWpGaD
Dabrafenib—RAF1—AGE/RAGE pathway—SMAD3—allergic rhinitis	5.78e-05	0.0112	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	5.76e-05	0.0111	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—MS4A2—allergic rhinitis	5.61e-05	0.0108	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—IL5—allergic rhinitis	5.54e-05	0.0107	CbGpPWpGaD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	5.04e-05	0.00976	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	4.89e-05	0.00947	CbGpPWpGaD
Dabrafenib—RAF1—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—allergic rhinitis	4.6e-05	0.0089	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—ADIPOQ—allergic rhinitis	4.59e-05	0.00889	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	4.58e-05	0.00887	CbGpPWpGaD
Dabrafenib—RAF1—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	4.22e-05	0.00816	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	4.16e-05	0.00805	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	3.99e-05	0.00771	CbGpPWpGaD
Dabrafenib—RAF1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	3.92e-05	0.00759	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL13—allergic rhinitis	3.92e-05	0.00759	CbGpPWpGaD
Dabrafenib—RAF1—Ceramide signaling pathway—NFKB1—allergic rhinitis	3.79e-05	0.00733	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	3.61e-05	0.00698	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	3.43e-05	0.00664	CbGpPWpGaD
Dabrafenib—RAF1—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	3.4e-05	0.00658	CbGpPWpGaD
Dabrafenib—RAF1—Interleukin-11 Signaling Pathway—TGFB1—allergic rhinitis	3.38e-05	0.00655	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL5—allergic rhinitis	3.35e-05	0.00649	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—SMAD3—allergic rhinitis	3.34e-05	0.00646	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—MS4A2—allergic rhinitis	3.33e-05	0.00644	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—SMAD3—allergic rhinitis	3.32e-05	0.00642	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	3.26e-05	0.0063	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	3.21e-05	0.0062	CbGpPWpGaD
Dabrafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	3.13e-05	0.00605	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	3.12e-05	0.00604	CbGpPWpGaD
Dabrafenib—BRAF—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	3.12e-05	0.00604	CbGpPWpGaD
Dabrafenib—RAF1—IL-3 Signaling Pathway—TGFB1—allergic rhinitis	3.11e-05	0.00601	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-G—allergic rhinitis	3.03e-05	0.00586	CbGpPWpGaD
Dabrafenib—RAF1—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	2.97e-05	0.00575	CbGpPWpGaD
Dabrafenib—RAF1—AGE/RAGE pathway—NFKB1—allergic rhinitis	2.94e-05	0.00568	CbGpPWpGaD
Dabrafenib—RAF1—BCR signaling pathway—NFKB1—allergic rhinitis	2.9e-05	0.00562	CbGpPWpGaD
Dabrafenib—RAF1—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	2.83e-05	0.00548	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	2.73e-05	0.00527	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	2.71e-05	0.00525	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—CD4—allergic rhinitis	2.66e-05	0.00515	CbGpPWpGaD
Dabrafenib—RAF1—Leptin signaling pathway—NFKB1—allergic rhinitis	2.65e-05	0.00513	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	2.6e-05	0.00502	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL5—allergic rhinitis	2.58e-05	0.005	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL10—allergic rhinitis	2.45e-05	0.00475	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL5—allergic rhinitis	2.44e-05	0.00472	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	2.44e-05	0.00472	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	2.42e-05	0.00469	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL4—allergic rhinitis	2.39e-05	0.00462	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—NFKB1—allergic rhinitis	2.29e-05	0.00444	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	2.25e-05	0.00436	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	2.25e-05	0.00436	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	2.19e-05	0.00424	CbGpPWpGaD
Dabrafenib—RAF1—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	2.16e-05	0.00418	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	2.02e-05	0.0039	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—NFKB1—allergic rhinitis	2.01e-05	0.00389	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	2e-05	0.00387	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—NFKB1—allergic rhinitis	1.98e-05	0.00383	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—MS4A2—allergic rhinitis	1.94e-05	0.00375	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—TGFB1—allergic rhinitis	1.91e-05	0.0037	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-DQB1—allergic rhinitis	1.89e-05	0.00366	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	1.88e-05	0.00363	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—PTGDR2—allergic rhinitis	1.8e-05	0.00349	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—CD4—allergic rhinitis	1.74e-05	0.00337	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-G—allergic rhinitis	1.73e-05	0.00334	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—NFKB1—allergic rhinitis	1.7e-05	0.00328	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	1.69e-05	0.00327	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TGFB1—allergic rhinitis	1.68e-05	0.00324	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—IL5—allergic rhinitis	1.61e-05	0.00311	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—ADIPOQ—allergic rhinitis	1.59e-05	0.00308	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—NFKB1—allergic rhinitis	1.57e-05	0.00305	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PTGDR2—allergic rhinitis	1.54e-05	0.00298	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—NFKB1—allergic rhinitis	1.5e-05	0.0029	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	1.46e-05	0.00283	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.42e-05	0.00274	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—TGFB1—allergic rhinitis	1.41e-05	0.00274	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	1.41e-05	0.00272	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—NFKB1—allergic rhinitis	1.39e-05	0.00269	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—ICAM1—allergic rhinitis	1.38e-05	0.00267	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL11—allergic rhinitis	1.37e-05	0.00265	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	1.33e-05	0.00258	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—NFKB1—allergic rhinitis	1.31e-05	0.00254	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.26e-05	0.00243	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CYSLTR1—allergic rhinitis	1.21e-05	0.00234	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL11—allergic rhinitis	1.17e-05	0.00226	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	1.16e-05	0.00224	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—SMAD3—allergic rhinitis	1.15e-05	0.00223	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	1.08e-05	0.00208	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTGDR2—allergic rhinitis	1.07e-05	0.00206	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-G—allergic rhinitis	1.05e-05	0.00203	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.05e-05	0.00202	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD4—allergic rhinitis	1.01e-05	0.00196	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	9.99e-06	0.00193	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—TAC1—allergic rhinitis	9.94e-06	0.00192	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	9.31e-06	0.0018	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	9.24e-06	0.00179	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL5—allergic rhinitis	9.24e-06	0.00179	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—NFKB1—allergic rhinitis	9.09e-06	0.00176	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—NFKB1—allergic rhinitis	8.73e-06	0.00169	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TAC1—allergic rhinitis	8.48e-06	0.00164	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL5—allergic rhinitis	8.44e-06	0.00163	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CYSLTR1—allergic rhinitis	8.36e-06	0.00162	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL11—allergic rhinitis	8.08e-06	0.00156	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SMAD3—allergic rhinitis	7.93e-06	0.00153	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL5—allergic rhinitis	7.89e-06	0.00153	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—ICAM1—allergic rhinitis	7.86e-06	0.00152	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DQB1—allergic rhinitis	6.53e-06	0.00126	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CD4—allergic rhinitis	6.02e-06	0.00116	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	5.92e-06	0.00115	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—NFKB1—allergic rhinitis	5.87e-06	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TAC1—allergic rhinitis	5.87e-06	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD4—allergic rhinitis	5.78e-06	0.00112	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SMAD3—allergic rhinitis	5.55e-06	0.00107	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SMAD3—allergic rhinitis	5.48e-06	0.00106	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL5—allergic rhinitis	5.46e-06	0.00106	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—NFKB1—allergic rhinitis	5.18e-06	0.001	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—NFKB1—allergic rhinitis	4.98e-06	0.000963	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	4.93e-06	0.000954	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—allergic rhinitis	4.89e-06	0.000946	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—allergic rhinitis	4.8e-06	0.000928	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ICAM1—allergic rhinitis	4.77e-06	0.000923	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CD4—allergic rhinitis	4.68e-06	0.000905	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SMAD3—allergic rhinitis	3.84e-06	0.000743	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD4—allergic rhinitis	3.5e-06	0.000678	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—allergic rhinitis	3.36e-06	0.00065	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CD4—allergic rhinitis	3.24e-06	0.000626	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NFKB1—allergic rhinitis	3.02e-06	0.000584	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NFKB1—allergic rhinitis	2.82e-06	0.000546	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—allergic rhinitis	2.35e-06	0.000455	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—allergic rhinitis	2.32e-06	0.000449	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NFKB1—allergic rhinitis	1.95e-06	0.000378	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—allergic rhinitis	1.63e-06	0.000315	CbGpPWpGaD
